What is Pristine Surgical?
Pristine Surgical LLC operates as a specialized entity in the medical technology sector, concentrating on the development and deployment of single-use surgical visualization systems. This innovative approach aims to enhance surgical procedures by providing clear, sterile visualization tools, thereby contributing to improved patient outcomes, increased safety protocols, and greater procedural efficacy. The company's focus on single-use technology addresses critical concerns regarding infection control and instrument reprocessing in healthcare settings.
How much funding has Pristine Surgical raised?
Pristine Surgical has raised a total of $33M across 2 funding rounds:
Series B
$18M
Series D
$15M
Series B (2020): $18M, investors not publicly disclosed
Series D (2022): $15M led by Ceros Capital Markets
Key Investors in Pristine Surgical
Ceros Capital Markets
Ceros Capital Markets is a global investing platform that specializes in fundraising for MedTech and Biotech companies, focusing on disruptive technologies in medical devices, robotics, and digital health. The firm primarily raises funds through Series A-D rounds for innovative companies developing non-invasive diagnostic procedures.
What's next for Pristine Surgical?
With the recent influx of major strategic investment, Pristine Surgical is poised for accelerated expansion and technological advancement. This substantial backing, contributing to the overall $33M in capital, suggests a strategic push towards scaling operations, further research and development, and potentially broader market penetration. The company's trajectory indicates a move towards solidifying its position as a key player in the surgical visualization market, likely focusing on enhancing its product offerings and expanding its reach to healthcare providers globally. This financing round is indicative of a company in a significant growth phase, aiming to capitalize on its innovative solutions.
See full Pristine Surgical company page
